Re: [NATAP] Glasgow: Reyataz Improved Body Fat by MRI????

[Guest guest]

Immunologic and viral response were preserved after changing antiretroviral therapy. Fasting triglyceride and cholesterol levels decreased during therapy with atazanavir. Remarkably, preexisting buffalo hump and waist size, respectively, were reduced. MRI yielded a 30% reduction of subcutaneous adipose tissue after switching to ATV.

******

I am confused..so Reyataz increased lipoatrophy? How about visceral fat, where the problem really is in the abdomen?

VergelDirectorProgram for Wellness Restoration, PoWeRA 501 © 3 non profit national organization"Only what we are not giving can be lacking in any situation"The Course of MiraclesLinks to our web sites:www.nelsonvergel.comwww.powerusa.orgwww.facialwasting.orgwww.salvagetherapies.orgJoin our free listservers by sending a blank email to:pozhealth-subscribe fuzeonsupport-subscribe

[Guest guest]

Fat was REDUCED. Subcutaneous fat was reduced. I saw pix of subc fat in poster. Jules

In a message dated 11/17/04 8:50:30 AM, PoWeRTX writes:

Immunologic and viral response were preserved after changing antiretroviral therapy. Fasting triglyceride and cholesterol levels decreased during therapy with atazanavir. Remarkably, preexisting buffalo hump and waist size, respectively, were reduced. MRI yielded a 30% reduction of subcutaneous adipose tissue after switching to ATV.

 

******

 

I am confused..so Reyataz increased lipoatrophy? How about visceral fat, where the problem really is in the abdomen?

 

Vergel

Director

Program for Wellness Restoration, PoWeR

A 501 © 3 non profit national organization

"Only what we are not giving can be lacking in any situation"

The Course of Miracles

Links to our web sites:

www.nelsonvergel.com

www.powerusa.org

www.facialwasting.org

www.salvagetherapies.org

Join our free listservers by sending a blank email to:

pozhealth-subscribe

fuzeonsupport-subscribe

[Guest guest]

At 03:35 PM 11/17/2004 -0500, you wrote:

>Fat was REDUCED. Subcutaneous fat was reduced. I saw pix of subc fat in

>poster. Jules

That waist size and, more importantly, buffalo humps, were reduced is a

good thing. I think the concern is whether the loss of sub-q fat may also

affect peripheral limb or facial fat--hence 's question. Visceral fat

related to lipomegaly would need to be reduced as well as sub-q. Also, one

should not presume this is an effect of Taz, but rather an attenuation of a

problem induced by other ARV.

It's a rather annoying tactic, too, for drug companies to say--lookahere!

Our drug does NOT cause this problem! Whee!! All well and good--unless a

problem that it DOES cause is downplayed or ignored. In the case of Taz, I

hope that the hyperbilirubinemia is not particularly relevant clinically,

for example, as many seem to claim. And let us not be quick to say it is a

miracle drug of utter harmlessness. I think caution is the order of the day

when it comes to pronouncements from Pharma, who have a penchant for lying

even as they are charging such lethally high prices and destabilizing our

patchwork, miserable, so-called " healthcare " system.

M.